Lenalidomide
NDC 69097-604, Lenalidomide, capsule, from Cipla USA Inc..
- Product NDC
- 69097-604
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214618
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-604 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LENALIDOMIDE2.5 mg/1
Pharmacologic classes
Thalidomide Analog [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-604-73 | 69097060473 | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/96df285d-dd13-4083-b2c6-e5c799e7587b
Use it
Look up 69097-604 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-604 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-604. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.